Search Results for

Showing 1 - 5 of 5 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Mentors

    Mentors ARVO Foundation is looking for members to serve as meeting mentors for visiting researchers from developing countries attending the ARVO Annual Meeting. As a meeting mentor, you will have the ability to influence the visiting researcher's experience before, during and after the ARVO Annual Meeting. Meeting mentor requirements include: Communicate with the visiting researcher prior to the Annual Meeting, acquainting them with the meeting and suggest how to plan their time. Help the

  3. Travel grants

    ARVO Foundation travel grants In 2002, the ARVO Foundation established and awarded its first travel grants. As of 2018, the Foundation has supported travel expenses for over 1,000 young researchers from around the world to report their work at the ARVO Annual Meeting. The Foundation currently offers 32 named travel grants that support over 180 researchers annually. Travel grants are awarded based on abstracts submitted to the ARVO Annual Meeting. Grants are awarded to the highest scored abst

  4. About

    About the DCERF program